Related Experiment Video
Updated: Mar 7, 2026
08:15
Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
Published on: May 10, 2024
1.0K
Diabetic nephropathy: A potential savior with 'rotten-egg' smell
1Department of Medicine, Aab Cardiovascular Research Institute, University of Rochester School of Medicine and Dentistry, Rochester, NY, USA.
Pharmacological Reports : PR
|February 10, 2017
Summary
Hydrogen sulfide (H2S) shows promise in preventing diabetic nephropathy (DN) progression by targeting key molecular pathways. This gasotransmitter may offer a novel therapeutic strategy for DN, a leading cause of kidney disease.
Area of Science:
- Nephrology
- Endocrinology
- Biochemistry
Background:
- Diabetic nephropathy (DN) is a primary cause of end-stage renal disease, contributing significantly to morbidity and mortality in diabetic patients.
- Pathological hallmarks of DN include extracellular matrix accumulation, mesangial expansion, glomerular basement membrane thickening, and tubulointerstitial fibrosis.
- Hyperglycemia drives DN via oxidative stress, TGF-β1 upregulation, inflammation, fibroblast activation, and ATP depletion.
Purpose of the Study:
- To review the therapeutic potential of hydrogen sulfide (H2S) in preventing diabetic nephropathy.
- To explore the molecular mechanisms underlying H2S's protective effects against DN development and progression.
- To discuss the future clinical applications of H2S as a novel therapy for DN.
Main Methods:
- Review of experimental findings on H2S and DN.
- Analysis of molecular pathways targeted by H2S in DN models.
- Discussion of preclinical data and potential clinical translation.
Main Results:
- Hydrogen sulfide (H2S) has demonstrated therapeutic characteristics in experimental animal models of DN.
- H2S targets multiple molecular pathways implicated in DN pathogenesis, including oxidative stress and inflammation.
- Preclinical studies suggest H2S can prevent the development and progression of DN.
Conclusions:
- Hydrogen sulfide (H2S) represents a potential novel therapeutic agent for diabetic nephropathy.
- Targeting H2S pathways may offer an alternative or complementary approach to current DN therapies.
- Further research into H2S's clinical application is warranted for managing DN.
Related Concept Videos
01:16Antihypertensive Drugs: Action of Diuretics
2.6K
Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various...
2.6K
01:15Antihypertensive Drugs: Thiazide-Class Diuretics
2.1K
Thiazide diuretics are sulfonamide derivatives featuring a benzothiadiazine ring system in their molecular structure. Based on this structure, thiazide diuretics can be categorized into two groups: thiazide-type and thiazide-like diuretics. Thiazide-type diuretics, including hydrochlorothiazide and chlorothiazide, consist of a benzothiadiazine backbone with an attached sulfonamide group. Thiazide-like diuretics, such as chlorthalidone and indapamide, lack the thiazide ring but demonstrate...
2.1K
01:22Heart Failure Drugs: Diuretics
1.1K
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
1.1K
01:30Heart Failure V: Medical Management
443
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
443
01:24Nephrotic Syndrome III : Nursing Management
402
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
402
01:27Dialysis
1.7K
Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
1.7K